Astellas Pharma Receivables 2012-2024 | ALPMY
- Astellas Pharma receivables for 2024 were $3.629B, a 8.26% increase from 2023.
- Astellas Pharma receivables for 2023 were $3.352B, a 1.21% increase from 2022.
- Astellas Pharma receivables for 2022 were $3.312B, a 2.92% increase from 2021.